114 related articles for article (PubMed ID: 6154055)
1. Controlled slow release of chemotherapeutic drugs for cancer from matrices prepared by radiation polymerization at low temperatures.
Kaetsu I; Yoshida M; Yamada A
J Biomed Mater Res; 1980 May; 14(3):185-97. PubMed ID: 6154055
[TBL] [Abstract][Full Text] [Related]
2. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
[TBL] [Abstract][Full Text] [Related]
3. Polystyrene nanoparticles based on poly(butyl methacrylate-g-methoxypoly(ethylene glycol)) and poly(methyl methacrylate-g-methoxypoly(ethylene glycol)) graft copolymers.
Horgan A; Vincent B
J Colloid Interface Sci; 2003 Jun; 262(2):536-47. PubMed ID: 16256636
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility and drug release behavior of spontaneously formed phospholipid polymer hydrogels.
Kimura M; Takai M; Ishihara K
J Biomed Mater Res A; 2007 Jan; 80(1):45-54. PubMed ID: 16958047
[TBL] [Abstract][Full Text] [Related]
5. Polymer-xerogel composites for controlled release wound dressings.
Costache MC; Qu H; Ducheyne P; Devore DI
Biomaterials; 2010 Aug; 31(24):6336-43. PubMed ID: 20510447
[TBL] [Abstract][Full Text] [Related]
6. Poly(glutamic acid) poly(ethylene glycol) hydrogels prepared by photoinduced polymerization: Synthesis, characterization, and preliminary release studies of protein drugs.
Yang Z; Zhang Y; Markland P; Yang VC
J Biomed Mater Res; 2002 Oct; 62(1):14-21. PubMed ID: 12124782
[TBL] [Abstract][Full Text] [Related]
7. Poly(ethylene glycol) methacrylate/dimethacrylate hydrogels for controlled release of hydrophobic drugs.
Diramio JA; Kisaalita WS; Majetich GF; Shimkus JM
Biotechnol Prog; 2005; 21(4):1281-8. PubMed ID: 16080712
[TBL] [Abstract][Full Text] [Related]
8. Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility.
Efentakis M; Pagoni I; Vlachou M; Avgoustakis K
Int J Pharm; 2007 Jul; 339(1-2):66-75. PubMed ID: 17408891
[TBL] [Abstract][Full Text] [Related]
9. A model for the drug release from a polymer matrix tablet--effects of swelling and dissolution.
Borgquist P; Körner A; Piculell L; Larsson A; Axelsson A
J Control Release; 2006 Jul; 113(3):216-25. PubMed ID: 16797098
[TBL] [Abstract][Full Text] [Related]
10. Design of a novel hydrogel-based intelligent system for controlled drug release.
He H; Cao X; Lee LJ
J Control Release; 2004 Mar; 95(3):391-402. PubMed ID: 15023451
[TBL] [Abstract][Full Text] [Related]
11. Controlled release of doxorubicin from thermosensitive poly(organophosphazene) hydrogels.
Kang GD; Cheon SH; Song SC
Int J Pharm; 2006 Aug; 319(1-2):29-36. PubMed ID: 16677786
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of acrylate-based block copolymers prepared by atom transfer radical polymerization as matrices for paclitaxel delivery from coronary stents.
Richard RE; Schwarz M; Ranade S; Chan AK; Matyjaszewski K; Sumerlin B
Biomacromolecules; 2005; 6(6):3410-8. PubMed ID: 16283773
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of proteins from degradable poly(ether-ester) multiblock copolymers.
van Dijkhuizen-Radersma R; Métairie S; Roosma JR; de Groot K; Bezemer JM
J Control Release; 2005 Jan; 101(1-3):175-86. PubMed ID: 15588903
[TBL] [Abstract][Full Text] [Related]
14. Solubilization and controlled release of a hydrophobic drug using novel micelle-forming ABC triblock copolymers.
Tang Y; Liu SY; Armes SP; Billingham NC
Biomacromolecules; 2003; 4(6):1636-45. PubMed ID: 14606890
[TBL] [Abstract][Full Text] [Related]
15. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix.
Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC
Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151
[TBL] [Abstract][Full Text] [Related]
16. Poly(trimethylene carbonate) and monomethoxy poly(ethylene glycol)-block-poly(trimethylene carbonate) nanoparticles for the controlled release of dexamethasone.
Zhang Z; Grijpma DW; Feijen J
J Control Release; 2006 Apr; 111(3):263-70. PubMed ID: 16481063
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of controlled-release preparation of mitomycin C in the treatment of inoperable cancer patients].
Hanyu F; Nakamura M; Takasaki T; Kasai Y; Sato T; Sato H; Sakurai Y; Yamada A; Okawa T; Sakabe T
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3087-93. PubMed ID: 2461168
[TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
19. Matrix modifications modulate ophthalmic drug delivery from photo-cross-linked poly(propylene fumarate)-based networks.
Haesslein A; Hacker MC; Ueda H; Ammon DM; Borazjani RN; Kunzler JF; Salamone JC; Mikos AG
J Biomater Sci Polym Ed; 2009; 20(1):49-69. PubMed ID: 19105900
[TBL] [Abstract][Full Text] [Related]
20. On-demand release by ultrasound from osmotically swollen hydrophobic matrices.
Aschkenasy C; Kost J
J Control Release; 2005 Dec; 110(1):58-66. PubMed ID: 16257468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
